Superbugs are teaming up!

Two superbugs – Klebsiella pneumoniae and Acinetobacter baumannii – are teaming up to make things worse in our hospitals.
Lizzie Thelwell
Lizzie Thelwell
Freelance Writer
Superbugs are teaming up!
Image credit: Getty Images

Two dangerous hospital bacteria are working together, increasing their virulence and resistance to antibiotics.

Sounds like the plot of a B-grade film, but unfortunately, as revealed in a new study from Macquarie University, it’s very much our reality.

“This is the culmination of 10 years of collaborative research into how pathogens interact with each other,” says Associate Professor Amy Cain, co-author of the new study.

“We were amazed to find that Klebsiella pneumoniae and Acinetobacter baumannii work together. And when they do, they are more deadly and more resistant to treatment.”

“They each have their own specialist job – one is feeding the other, and the other is providing antibiotic resistance,” says Amy.

This discovery has significant implications for hospital screening methods and treatment options.

Klebsiella pneumoniae (red) and Acinetobacter baumannii (yellow) growing together on differential media | Dr Lucie Semenec, Macquarie University

Top of the list for resistance

There are six escape pathogens, or ‘superbugs’ as we know them, that form most hospital-acquired infections.

Both Klebsiella pneumoniae and Acinetobacter baumannii are at the top of the World Health Organization’s list of bacteria in urgent need of new antibiotics.

Working together, these two pathogens create more biofilm – a sticky and strong protective layer. Biofilms form on implanted medical devices such as catheters and replacement implants, causing infections that antibiotics struggle to treat.

“They are really dangerous and especially dangerous for immunocompromised patients,” says Amy.

“Klebsiella pneumoniae is always around, but Acinetobacter baumannii tends to go in cycles, with some years being worse than others.”

Scanning EM of Klebsiella pneumoniae and Acinetobacter baumannii growing in a biofilm | Dr Lucie Semenec, Macquarie University

What’s truly terrifying is that these pathogens can live in hospitals on walls and other hospital surfaces for up to 4 months. Recent research also tells us Acinetobacter baumannii can live without water for 1 year and then become infectious again if given the right environment.

The discovery

Australian hospitals do not provide data for infection rates of these two bacteria growing together, so Amy and fellow co-author Dr Lucie Semenec turned to European data.

The data from Europe showed that, in almost half of all infections caused by one of these pathogens, the other one was present.

Armed with this information, the team from Macquarie University began experimenting with caterpillars of the greater wax moth, Galleria mellonella.

Galleria mellonella – moth or bark? | dhobern via Wikimedia Commons

As the immune system of this caterpillar is somewhat similar to humans, it provided an ethical alternative to using mice. Dr Nicole Bzdyl from the Marshall Centre at UWA has been awarded a research grant to join Amy’s laboratory to learn how to use and develop infection models with the caterpillars to test new drug therapies.

According to Amy, while looking at the caterpillars, the team found the two bacteria could infect the larvae via collaborative effort.

“We looked at their genome and used RNA sequencing to understand which genes are switched on, and we could see they were activated together,” says Amy.

“We also used an electron microscope to see that they were literally interacting with each other.”

The team also put both bacteria in different media in a cross-feeding experiment. The experiment showed that both bacteria feed each other but Klebsiella pneumoniae eats more sugar than Acinetobacter baumannii.

The need to change screening methods

“This research adds another piece of information for policy makers,” says Amy.

“Hospitals need to routinely screen for the presence of multiple species within infections because even low levels of another bacterium can affect outcomes. Then if patients aren’t responding to treatment, clinicians can use an antibiotic that will cover both pathogens,” she adds.

“Combination therapy tends to be used more and more because we’re running out of options.”

According to Amy, the longer someone is inside a hospital, the higher their risk of developing a second infection.

“We need to take our hospital stays more seriously and think twice about unnecessary visits.”

Lizzie Thelwell
About the author
Lizzie Thelwell
Lizzie is a journalist, copywriter and communications professional. She writes about a wide variety of topics but has a particular interest in health and medicine.
View articles
Lizzie is a journalist, copywriter and communications professional. She writes about a wide variety of topics but has a particular interest in health and medicine.
View articles


We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.


Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.


You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.


Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.


All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.


For more information about using our content, email us:

Copy this HTML into your CMS
Press Ctrl+C to copy